Structures by: Dallemagne P.
Total: 3
6,7-dimethoxy-1-methyl-1,4-dihydroindeno[1,2-<i>c</i>]pyrazol-4-amine dihydrochloride
C13H17N3O2,2(Cl),2(H2O)
MedChemComm (2013) 4, 6 925
a=7.2598(2)Å b=10.0853(3)Å c=12.2011(3)Å
α=101.0100(10)° β=93.643(2)° γ=100.4820(10)°
<i>N</i>-{(5E)-5-[(dimethylamino)methylene]-6-oxo-5,6-dihydro-4<i>H</i>-cyclopenta[<i>b</i>]thien-4-yl}-2.2,2-trifluoroacetamide
C12H11F3N2O2S
MedChemComm (2013) 4, 6 925
a=6.7601(2)Å b=8.9249(3)Å c=22.5441(5)Å
α=90.00° β=97.265(2)° γ=90.00°
5-((1-(4-methoxybenzyl)piperidin-4-yl)methyloxy)pyrrolo (1,2- a)thieno(3,2-e)pyrazine
C23H25N3O2S
MedChemComm (2012) 3, 5 627
a=18.4455(5)Å b=5.8641(2)Å c=20.5004(6)Å
α=90.00° β=114.0670(10)° γ=90.00°